What's happening with specialised commissioning in the NHS?
Pharma Market Access Insights - from Petauri Evidence - Ein Podcast von Petauri Evidence
Kategorien:
What’s happening with specialised commissioning in the NHS? How likely is a delay in delegation to integrated care boards (ICBs)? How and what should Pharma and Medtech plan for amidst all this uncertainty? Malcolm Qualie (former Medicines Lead for Specialised Services, NHS England) speaks to David Thorne (Principal Associate, Mtech Access) to explore specialised commissioning in the NHS and what to expect as we head into 2024. Malcolm Qualie and David Thorne explored: Specialised commissio...
